19
Views
9
CrossRef citations to date
0
Altmetric
Research Article

Low Effectiveness of Highly Active Antiretroviral Therapy and High Mortality in the Greenland HIV-infected Population

, , , , &
Pages 738-742 | Published online: 23 Dec 2012

  • CIA. World Factbook. 18–12–2003. CIA. [Cited 2004 May 20]. Available from: URL: http://www.cia.gov/cia/publications/factbook/geos/gl.html#Intro
  • Misfeldt J, Melbye M, Hansen JP. An international meeting on preventing AIDS in the polar regions. Ilulissat/Jakobshavn 26 28 September 1989. Ugeskr Laeger 1989; 151: 3496.
  • Moi H, Froms E, Olsen J, Misfeldt J, Melbye M. Changes in knowledge of HIV/AIDS, sexual behaviour and practice among STD patients in Greenland 1990-1992. Monitoring the Stop-AIDS campaign in Greenland. Arctic Med Res 1993; 52: 145–52.
  • Stenz F, Koch AL, Friborg J, Olsen OR. Infectious Diseases in Greenland, part 2. EPI-NEWS, Statens Seruminstitut (8). 19–2–2003. Copenhagen. [Cited 2004 May 20]. Available from: URL: http://www.ssi.dk/sw6519.asp
  • AIDS and other sexually transmitted diseases in the Arctic regions. Arctic Med Res 1990; 49(Suppl 3): 1 38.
  • Olsen OR, Koch AL, Krause TG, Barselajsen G, Christiansen CB, Melbye M. Population screening for HIV in Sisimiut, Greenland. Ugeskr Laeger 2000; 162: 14652–5.
  • Jensen-Fangel S, Pedersen C, Larsen CS, Tauris P, Møller A, Obel N. Changing demographics in an HIV-infected population: results from an observational cohort study in western Denmark. Scand J Infect Dis 2001; 33: 765–70.
  • Misfeldt JC. Dramatic decline in the incidence of gonorrhoea and syphilis in Greenland: result of an intervention strategy? Ugeskr Laeger 1994; 156: 4690–4.
  • Statistics Greenland. 2004. [Cited 2004 May 20], Available from: URL: http://www.statgreen.gl/english
  • Jensen-Fangel S, Pedersen L, Pedersen C, Larsen CS, Tauris P, Moiler A, et al. Low mortality in HIV-infected patients starting HAART in advance of immunological deterioration: a comparison with the general population. AIDS 2004; 18: 89–97.
  • Malyutina S, Bobak M, Kurilovitch S, Gafarov V, Simonova G, Nikitin Y, et al. Relation between heavy and binge drinking and all-cause and cardiovascular mortality in Novosibirsk, Russia: a prospective cohort study. Lancet 2002; 360: 1448–54.
  • Rehm J, Greenfield TK, Rogers JD. Average volume of alcohol consumption, patterns of drinking, and all-cause mortality: results from the US National Alcohol Survey. Am J Epidemiol 2001; 153: 64–71.
  • Jaggy C, von Overbeck J, Ledergerber B, Schwarz C, Egger M, Rickenbach M, et al. Mortality in the Swiss HIV Cohort Study (SHCS) and the Swiss general population. Lancet 2003; 362: 877–8.
  • Mocroft A, Ledergerber B, Katlama C, Kirk O, Reiss P, D’Arminio MA, et al. Decline in the AIDS and death rates in the EuroSIDA study: an observational study. Lancet 2003; 362: 22–9.
  • WHO and UNAIDS. AIDS Epidemic Update. 2003. [Cited 2004 May 20]. Available from: URL: http://www.unaids.org/Unaids/EN/Resources/Publications/corporate-(-publications/ aids+epidemic+update+-+ december+2003. asp
  • Galvan FH, Bing EG, Bluthenthal RN. Accessing HIV testing and care. J Acquir Immune Defic Syndr 2000; 25\(Suppl 2): S151–6.
  • Moore RD, Keruly JC, Chaisson RE. Differences in HIV disease progression by injecting drug use in HIV-infected persons in care. J Acquir Immune Defic Syndr 2004; 35: 46–51.
  • Wood E, Montaner JS, Tyndall MW, Schechter MT, O’Shaughnessy MV, Hogg RS. Prevalence and correlates of untreated human immunodeficiency virus type 1 infection among persons who have died in the era of modem antiretroviral therapy. J Infect Dis 2003; 188: 1164–70.
  • Jensen-Fangel S, Pedersen L, Pedersen C, Larsen CS, Tauris P, Møller A, et al. The effect of race/ethnicity on the outcome of highly active antiretroviral therapy for human immunodeficiency virus type 1-infected patients. Clin Infect Dis 2002; 35: 1541–8.
  • Kebba A. Antiretroviral therapy in sub-Saharan Africa: myth or reality? J Antimicrob Chemother 2003; 52: 747–9.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.